Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated Cisplatin.
Siemer S, Bauer TA, Scholz P, Breder C, Fenaroli F, Harms G, Dietrich D, Dietrich J, Rosenauer C, Barz M, Becker S, Strieth S, Reinhardt C, Fauth T, Hagemann J, Stauber RH.
Siemer S, et al. Among authors: fauth t.
ACS Nano. 2021 Nov 23;15(11):18541-18556. doi: 10.1021/acsnano.1c08632. Epub 2021 Nov 5.
ACS Nano. 2021.
PMID: 34739225